Majidova, Nargiz, et al. “Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG)”. Turkish Journal of Gastroenterology, vol. 36, no. 5, Apr. 2025, pp. 293-01, doi:10.5152/tjg.2025.24784.